PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32535982-6	2020	Additionally, using the selective melatonin MT2 receptor antagonist 4-Phenyl-2-Propionamidotetralin (4P-PDOT), we discovered that the pharmacological effects of MLT upon NMDAR impairments were mediated by melatonin MT2 receptors.	4-phenyl-2-propionamidotetraline	101-108	glutamate receptor, ionotropic, NMDA1 (zeta 1)	Mus musculus	170-175